Dale Pfost, currently a general partner at Advent Ventures, has over 25 years of leadership experience in the biotechnology industry. He has served as chief executive of six biotechnology companies, most recently as founding CEO of NuMe Health. Previously, Dr. Pfost was CEO of cancer drug company Receptor BioLogix, founding CEO and chairman of ophthalmic innovator Acuity Pharmaceuticals, CEO and chairman of DNA testing company Orchid BioSciences, and president and CEO of Oxford GlycoSciences. Three of these companies became publically traded. Dr. Pfost received a B.S. degree from the University of California, Santa Barbara and a Ph.D. in physics from Brown University. Dr. Pfost joined The J.M. Burguières Co., Limited Board of Directors in 2010.
The J.M. Burguières Co., Limited was founded in 1877 from three plantations and has prospered through the years as a land acquisition and holding company with property interests in south Louisiana, south Florida and west Texas. The company is the largest single family-owned land holding company currently in operation in Louisiana.Read More